These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
537 related items for PubMed ID: 35341614
1. "You have to take this medication, but then you get punished for taking it:" lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period. Schiff DM, Work EC, Muftu S, Partridge S, MacMillan KDL, Gray JR, Hoeppner BB, Kelly JF, Greenfield SF, Jones HE, Wilens TE, Terplan M, Bernstein J. J Subst Abuse Treat; 2022 Aug; 139():108765. PubMed ID: 35341614 [Abstract] [Full Text] [Related]
2. Prescribed and Penalized: The Detrimental Impact of Mandated Reporting for Prenatal Utilization of Medication for Opioid Use Disorder. Work EC, Muftu S, MacMillan KDL, Gray JR, Bell N, Terplan M, Jones HE, Reddy J, Wilens TE, Greenfield SF, Bernstein J, Schiff DM. Matern Child Health J; 2023 Dec; 27(Suppl 1):104-112. PubMed ID: 37253899 [Abstract] [Full Text] [Related]
3. Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails. Sufrin C, Kramer CT, Terplan M, Fiscella K, Olson S, Voegtline K, Latkin C. JAMA Netw Open; 2022 Jan 04; 5(1):e2144369. PubMed ID: 35050354 [Abstract] [Full Text] [Related]
4. The Lived Experiences of Pregnant and Parenting Women in Recovery Toward Medication Treatment for Opioid Use Disorder. Titus-Glover D, Shaya FT, Welsh C, Roane L. Subst Use Addctn J; 2024 Jul 04; 45(3):367-377. PubMed ID: 38254261 [Abstract] [Full Text] [Related]
5. Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance. Klaman SL, Isaacs K, Leopold A, Perpich J, Hayashi S, Vender J, Campopiano M, Jones HE. J Addict Med; 2017 Jul 04; 11(3):178-190. PubMed ID: 28406856 [Abstract] [Full Text] [Related]
6. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study. Sufrin C, Sutherland L, Beal L, Terplan M, Latkin C, Clarke JG. Addiction; 2020 Nov 04; 115(11):2057-2065. PubMed ID: 32141128 [Abstract] [Full Text] [Related]
9. Prescribing and Acceptance of Medications for Opioid Use Disorder in VA Primary Care: Veteran and Provider Perspectives. Bergman AA, Oberman RS, Taylor SL, Kranke B, Chang ET. J Gen Intern Med; 2024 Jul 04; 39(9):1690-1697. PubMed ID: 38587730 [Abstract] [Full Text] [Related]
10. Spatial and Nonspatial Factors Associated with Access to Medication for Opioid Use Disorder among Pregnant Women in Massachusetts. Joshi C, Ho Chui KK, Skeer MR, Stopka TJ. Subst Use Misuse; 2022 Jul 04; 57(13):1904-1917. PubMed ID: 36219099 [Abstract] [Full Text] [Related]
15. Lessons from the First Wave of COVID-19 for Improved Medications for Opioid Use Disorder (MOUD) Treatment: Benefits of Easier Access, Extended Take Homes, and New Delivery Modalities. Walters SM, Perlman DC, Guarino H, Mateu-Gelabert P, Frank D. Subst Use Misuse; 2022 Jul 04; 57(7):1144-1153. PubMed ID: 35443862 [Abstract] [Full Text] [Related]
18. "Just give them a choice": Patients' perspectives on starting medications for opioid use disorder in the ED. Schoenfeld EM, Westafer LM, Beck SA, Potee BG, Vysetty S, Simon C, Tozloski JM, Girardin AL, Soares WE. Acad Emerg Med; 2022 Aug 04; 29(8):928-943. PubMed ID: 35426962 [Abstract] [Full Text] [Related]